PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12830260::ACT034421

TXM-CB3

Evidence text

Paper-level observation

Fig. 2E: CB3 treatment experience significantly lower seizure duration (p < 0.0001).
textConfidence: medium

Assay observation

Activity
Other
Subtype
Not reported by source
Measure
other
Comparator
<
Raw observation
significantly lower seizure duration seconds
Normalized measurement
<0.0001 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
ACCPCNH
Standardization
ready simple
Assay conditions
"original_unit=seconds"

Source publication

Thioredoxin-mimetic peptide attenuates epilepsy progression and neurocognitive deficits

Redox Biology · 2026

DOI 10.1016/j.redox.2026.104021 PMC12830260
Parent mention

Related peptide identities

PEPDIA-PLP-000024

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.